Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI106915

The pathogenesis of Shigella Diarrhea: I. Enterotoxin production by Shigella dysenteriae 1

Gerald T. Keusch, George F. Grady, Leonardo J. Mata, and James McIver

Biologic Laboratories, State Laboratory Institute, Massachusetts Department of Public Health, Boston, Massachusetts 02114

Division of Infectious Diseases, Department of Medicine, Mount Sinai School of Medicine, New York 10029

Find articles by Keusch, G. in: PubMed | Google Scholar

Biologic Laboratories, State Laboratory Institute, Massachusetts Department of Public Health, Boston, Massachusetts 02114

Division of Infectious Diseases, Department of Medicine, Mount Sinai School of Medicine, New York 10029

Find articles by Grady, G. in: PubMed | Google Scholar

Biologic Laboratories, State Laboratory Institute, Massachusetts Department of Public Health, Boston, Massachusetts 02114

Division of Infectious Diseases, Department of Medicine, Mount Sinai School of Medicine, New York 10029

Find articles by Mata, L. in: PubMed | Google Scholar

Biologic Laboratories, State Laboratory Institute, Massachusetts Department of Public Health, Boston, Massachusetts 02114

Division of Infectious Diseases, Department of Medicine, Mount Sinai School of Medicine, New York 10029

Find articles by McIver, J. in: PubMed | Google Scholar

Published May 1, 1972 - More info

Published in Volume 51, Issue 5 on May 1, 1972
J Clin Invest. 1972;51(5):1212–1218. https://doi.org/10.1172/JCI106915.
© 1972 The American Society for Clinical Investigation
Published May 1, 1972 - Version history
View PDF
Abstract

A strain of Shigella dysenteriae 1, freshly isolated from a patient with dysentery in Guatemala in August 1969, was found to elaborate an enterotoxin into the liquid of broth cultures. Partial purification of the enterotoxin by ultrafiltration on graded polymeric membranes and Sephadex gel filtration (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) suggested an approximate molecular weight of 55,000-60,000. The partially purified toxin was heat-labile, pronase sensitive, and activated by alkaline pH, and it elicited fluid production in ligated rabbit ileal segments; it failed, however, to cause increased vascular permeability in skin. When the activities of equal weights of identically prepared Vibrio cholerae and S. dysenteriae enterotoxins were compared in the rabbit ileum the latter caused a significantly smaller volume response with increased concentrations of potassium, chloride, and protein.

The previously described neurotoxic (mouse lethal) factor was also present and eluted from Sephadex G-150 with the enterotoxin. If these biological activities prove to be possessed by a single molecular species, it is suggested that it be renamed Shigella enterotoxin in recognition of the physiologically more relevant biological action.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1212
page 1212
icon of scanned page 1213
page 1213
icon of scanned page 1214
page 1214
icon of scanned page 1215
page 1215
icon of scanned page 1216
page 1216
icon of scanned page 1217
page 1217
icon of scanned page 1218
page 1218
Version history
  • Version 1 (May 1, 1972): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts